27d agoThe FlyBULLISH 61Analyst
Archived explainer. For the current picture see today's CADL page.
Why Is CANDEL THERAPEUTICS (CADL) Stock Moving Today?
By the Top Tier Newswire AI Desk · August 17, 2026 at 2:12 AM ET · reviewed against 1 wire stories
CANDEL THERAPEUTICS (CADL) is drawing unusual attention today. Our newswire has captured 1 story on CADL across 1 source in the last 36 hours, with AI sentiment reading bullish (avg 61/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
CADL stock is moving higher today amid a recent price target upgrade from BofA. The stock closed up 4.2% as the firm raised its price target to $12 from $9. The move reflects renewed optimism about the company's pipeline despite ongoing earnings challenges.
What Happened
BofA Securities increased its price target for Candel Therapeutics to $12 from $9, signaling a more positive outlook. The firm maintains a neutral stance on the stock. This follows a recent update on the company's clinical development, with Candel Therapeutics initiating its pivotal Phase 3 AURORA study of aglatimagene besadenovec plus valacyclovir in combination with continued pembrolizumab in participants with metastatic non-squamous non-small cell lung cancer. The stock has been volatile in recent months, having traded between $4.35 and $11.95 over the past 52 weeks.
What The Data Shows
The stock has printed two fresh 52-week highs on August 17. Recent insider transactions show two sales totaling $306K in the last 90 days, with the most recent filing on July 1. The company remains unprofitable, with a trailing twelve-month EPS of -0.97 and a market cap of $775.2M. Volume has not been reported as unusually high, but the stock’s recent price action suggests increased investor attention.
What To Watch
Candel Therapeutics is not scheduled to report earnings in the near term. Investors should monitor the breadth of coverage as additional analyst ratings could influence the stock’s trajectory.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
CADL by the numbers
Coverage: 1 stories / 1 sourcesAI sentiment: 61/100 (bullish)Mkt cap: $775M52w: $4.35 to $11.95
The headlines behind the move
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on CADL: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier CADL move explainers: 2026-08-17